Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research

Volumn 10, Issue 7, 2004, Pages 2299-2306

  Yokoi, Kenji ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; IC 50; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANOXIA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BUTADIENES; CELL DIVISION; CELL LINE, TUMOR; CHROMONES; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; NITRILES; OXYGEN; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PYRIMIDINES; PYRROLES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; TYROSINE;

EID: 1842583652     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0488     Document Type: Article

References (37)

1. Bardeesy N, Depinho RA. Pancreatic cancer biology and genetics. Nature Rev 2002;2:897-909.
2. Gansauge S, Gansauge F, Beger HG. Molecular oncology in pancreatic cancer. J Mol Med 1996;74:313-20.
3. Coppola D. Molecular prognostic markers in pancreatic cancer. Cancer Control 2000;7:421-7.
4. Abbruzzese JL. New application of gemcitabine and future directions in the management of pancreatic cancer. Cancer (Phila.) 2002;95:941-5.
5. Chakravarti A, Chakladar A, Dekaney MA, Lathman DE, Loeffler JS. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a ras-dependent manner. Cancer Res 2002; 62:4307-15.
6. Ghaneh P, Kawesha A, Evans JD, Neoptolemos JP. Molecular prognostic markers in pancreatic cancer. J Hepatobiliary Pancreat Surg 2002;9:1-11.
7. Bruns CJ, Solorzano CC, Harbison MT, et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res 2000;60:2926-35.
8. Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002;62: 1996-2003.
9. Yamanaka Y, Friess H, Kobrin MS, et al. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993; 13:565-9.
10. Perugini RA, McDade TP, Vittimberga FJ, Callery MP. Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent. J Surg Res 2000;90:29-44.
11. Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 2002;14:381-95.
12. De Bono JS, Rowinsky EK. Therapeutics targeting signal transduction for patients with colorectal carcinoma. Br Med Bull 2002;64: 227-54.
13. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003;3:17-22.
14. Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt: implication for cancer therapy. Pharmacol Ther 2002;93:243-51.
15. Krasilnikov MA. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry 2000;65:59-67.
16. Ng SSW, Tsao M-S, Chow S, Hedley DW. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 2000;60:5451-5.
17. Ng SSW, Tsao M-S, Nicklee T, Hedley DW. Wortmannin inhibits PKB/Akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clin Cancer Res 2001;7:3269-75.
18. Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB, McConkey DJ. Inhibition of the phosphatidylinositol 3′-kinase-Akt pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther 2002;1:989-97.
19. Wang W, Abbruzzese JJ, Evans DB, et al. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-27.
20. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukocyte Biol 2002;72: 847-55.
21. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbit by monoclonal antibody to IL-8. Lab Investig 1997;76:375-84.
22. Shi Q, Abbruzzese JL, Huang S, et al. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 1999;5:3711-21.
23. Li A, Varney ML, Singh RK. Expression of interleukin-8 and its receptor in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001;7:3298-304.
24. Harris AL. Hypoxia: a key regulatory factor in tumor growth. Nature Rev 2002;2:38-47.
25. Seta KA, Spicer Z, Yuan Y, Lu G, Millhorn DE. Responding to hypoxia: lessons from a model cell line. Science (Wash. DC) 2002; 146:1-16.
26. Chen EY, Mazure NM, Cooper JA, Giaccia A. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/ Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 2001;61:2429-33.
27. Bruns CJ, Harbison MT, Davis DW, et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 2000; 6:1936-48.
28. Traxler P, Bold G, Buchdunger E, et al. Tyrosine kinase inhibitors: from rational design to clinical trials. Med Res Rev 2001;21: 499-512.
29. Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res 1999;59:5822-9.
30. Jiang Z, Zhang Y, Chen X, et al. Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun 2002;294:726-33.
31. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, et al. Hypoxia induced the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells. J Biol Chem 2001;276:22368-74.
32. Zhou BP, Hu MC-T, Miller SA, et al. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway. J Biol Chem 2000;275:8027-31.
33. Quincey AJ, Clinton GM. Herstain, an auto-inhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathway resulting in growth arrest. J Biol Chem 2002;277:20618-24.
34. Alroy I, Yarden Y. The erbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-6.
35. Schlessinger J. Cell signaling receptor tyrosine kinases. Cell 2000; 103:211-25.
36. Zhang SQ, Tsiaras WG, Araki T, et al. Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2. Mol Cell Biol 2002;22:4062-72.
37. Jung F, Haendeler J, Hoffmann J, et al. Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein shc in endothelial cells. Circ Res 2002;91:38-45.